BRWA
MDCO

B. Riley Wealth Advisors’s Medicines Co MDCO Stock Holding History

B. Riley Wealth Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-37
Closed -$1 – 2282
2014
Q4 		$1 Buy
+37
New +$917 ﹤0.01% 3617

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

B. Riley Wealth Advisors's MDCO Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Medicines Co (MDCO) in Q1 2015, closing a stake of 37 shares — an estimated $1 sold.

B. Riley Wealth Advisors first reported a position in MDCO in Q4 2014 and held it in 1 quarter. The position peaked at $1 in Q4 2014. 184 funds tracked by Wall St. Rank hold MDCO as of Q1 2015.

  • B. Riley Wealth Advisors reported no remaining Medicines Co position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 37 Medicines Co shares in Q1 2015, an estimated $1.
  • B. Riley Wealth Advisors first reported a position in Medicines Co in Q4 2014 and held it in 1 quarter.
  • B. Riley Wealth Advisors's Medicines Co position peaked at $1 in Q4 2014.
  • 184 funds tracked by Wall St. Rank held Medicines Co as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.